You have 9 free searches left this month | for more free features.

City

Boston (3)

Los Angeles (1)

San Antonio (1)

Scottsdale (1)

Condition

Acute Myeloid Leukemia, in Relapse (1)

Multiple Myeloma (1)

Multiple Myeloma in Relapse (1)

Recurrent Adult Acute Myeloid Leukemia (1)

Refractory Multiple Myeloma (1)

Solid Tumors (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Withdrawn (1)

Sign in for free

Phase

phase 1 (2)

phase 1/phase 2 (1)

Sponsor

Dana-Farber Cancer Institute (2)

Genus Oncology, LLC (1)

Collaborator

Genus Oncology, LLC (1)

National Institutes of Health (NIH) (1)

Intervention

go-203-2c (3)

bortezomib (1)

go-203-2c + decitabine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

go-203-2c

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia, in Relapse, Recurrent Adult Acute Myeloid Leukemia Trial in Boston (GO-203-2c, GO-203-2c + Decitabine)

Active, not recruiting

Acute Myeloid Leukemia, in Relapse
Recurrent Adult Acute Myeloid Leukemia

GO-203-2c
GO-203-2c + Decitabine

Boston, Massachusetts
+1 more

Jan 25, 2022

Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in Boston (GO-203-2C, Bortezomib)

Withdrawn

Multiple Myeloma
+2 more

GO-203-2C
Bortezomib

Boston, Massachusetts
+1 more

Jun 30, 2017

Solid Tumors Trial in United States (GO-203-2c)

Completed

Solid Tumors

GO-203-2c

Scottsdale, Arizona
+3 more

Sep 18, 2014